EUVIMEDEUVIMED entdecken
Open Access

Prodromal Peripheral Immune Cell Profile in Drug‐Induced Parkinsonism Relative to Parkinson's Disease

Brandon Lien iD, Varun Kasibhatla, Mariel Mawad, Jenee Anekwe, Joseph H Friedman iD, Saud Alhusaini iD

Movement Disorders Clinical Practice · 2025

DOI: 10.1002/mdc3.70476 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Brandon Lien und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, The Warren Alpert Medical School of Brown University, Providence, RI, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Prodromal Symptoms, Neutrophils, Parkinson Disease, Secondary. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Rhode Island Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug‐induced Parkinsonism (DIP) is a predictor of future idiopathic Parkinson's disease (PD), yet the prodromal characteristics of DIP remain unexplored.

Objectives

To compare prodromal peripheral immune cell profiles in DIP and PD.

Methods

We applied independent regression models to evaluate the peripheral immune cell profiles in individuals with incident DIP (n = 108) and PD (n = 1055) relative to 20,070 healthy controls from the UK Biobank.

Results

Approximately 9 years before diagnosis, both DIP and PD cases exhibited elevated neutrophil counts, neutrophil‐to‐lymphocyte ratio (NLR), and systemic immune‐inflammation index (SII). Only PD cases showed reduced lymphocyte counts. After adjusting for psychiatric comorbidities, DIP‐associated peripheral immune alterations were no longer significant.

Conclusions

The elevated neutrophil counts in DIP and PD suggest a shared innate immune system involvement. However, in DIP, the peripheral immune changes appear driven by psychiatric comorbidities, whereas lymphopenia may represent a distinctive prodromal biomarker of PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseProdromal SymptomsNeutrophilsParkinson Disease, SecondaryParkinsonian DisordersHumansMaleFemaleMiddle AgedAgedLymphocytes

Stichwörter der Autor:innen

Parkinson's diseasedrug‐induced parkinsonismneutrophil‐to‐lymphocyte ratioperipheral inflammation

Autor:innen und Institutionen

  • Neurology Department, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
  • The Movement Disorders Program, Butler Hospital, Providence, RI, USA.
  • The Movement Disorders Program, Rhode Island Hospital, Brown University Health, Providence, RI, USA.

ORCID-Profile: Brandon Lien, Joseph H Friedman, Saud Alhusaini

Förderung

  • Rhode Island Foundation

Zitieren

APA

Lien, B., Kasibhatla, V., Mawad, M., Anekwe, J., Friedman, J. H., & Alhusaini, S. (2025). Prodromal Peripheral Immune Cell Profile in Drug‐Induced Parkinsonism Relative to Parkinson's Disease. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70476

Vancouver

Lien B, Kasibhatla V, Mawad M, Anekwe J, Friedman JH, Alhusaini S. Prodromal Peripheral Immune Cell Profile in Drug‐Induced Parkinsonism Relative to Parkinson's Disease. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70476

BibTeX
@article{Lien2025,
  author = {Lien, Brandon and Kasibhatla, Varun and Mawad, Mariel and Anekwe, Jenee and Friedman, Joseph H and Alhusaini, Saud},
  title = {Prodromal Peripheral Immune Cell Profile in Drug‐Induced Parkinsonism Relative to Parkinson's Disease},
  journal = {Movement Disorders Clinical Practice},
  year = {2025},
  doi = {10.1002/mdc3.70476}
}
Kostenlos starten →